Worm, M.; Reese, I.; Ballmer-Weber, B. et al.
Guideline for Management of IgE-mediated Food AllergiesALLERGOLOGIE. Bd. 39. H. 7. 2016 S. 302-344
Krumm, A.; Barckhausen, C.; Kuecuek, P. et al.
HDAC1/HDAC2/HDAC3 mediated RAD51 and FANCD2 expression contribute to the resistance of melanoma cells to alkylating chemotherapeuticsONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 150-150
Roos, W.; Krumm, A.; Barckhausen, C. et al.
HDAC1/HDAC2/HDAC3 mediated RAD51 and FANCD2 expression contribute to the resistance of melanoma cells to temozolomide and fotemustineJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 15-15
Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel et al.
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanomaEUROPEAN JOURNAL OF CANCER. Bd. 67. 2016 S. 46-54
Peveling-Oberhag, Adriane; Reimann, Holger; Weyer, Veronika et al.
High-Concentration Liquid Prednisolone Formula: Filling a Therapeutic Niche in Severe Acute Attacks of Urticaria and AngioedemaSKIN PHARMACOLOGY AND PHYSIOLOGY. Bd. 29. H. 1. 2016 S. 9-12
Maurer, M.; Raap, U.; Staubach, P. et al.
Hospital compared to private practice dermatologist treatment of chronic spontaneous urticaria: baseline characteristics and treatment patterns from the German AWARE (A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation) studyALLERGY. Bd. 71. 2016 S. 184-184
Rahimi-Nedjat, R. K.; Sagheb, K.; Tuettenberg, A. et al.
How is Your Diagnosis? Localized, irregular Pigmentation of the Maxillary GingivaHAUTARZT. Bd. 67. H. 4. 2016 S. 326-329
Fridrich, Sven; Hahn, Susanne A.; Linzmaier, Marion et al.
How Soluble GARP Enhances TGF beta ActivationPLOS ONE. Bd. 11. H. 4. 2016
Tomcin, Stephanie; Kelsch, Annette; Staff, Roland H. et al.
HPMA-based block copolymers promote differential drug delivery kinetics for hydrophobic and amphiphilic moleculesACTA BIOMATERIALIA. Bd. 35. 2016 S. 12-22
Domogalla, M. P.; Frick, S. U.; Baier, G. et al.
Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinitiesEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E24-E24